Senate Health Committee, Wednesday, February 18, 2026

California State Senate Health Committee · February 18, 2026

0:00/2:35

2:35:43

0:00

30:00

1:00:00

1:30:00

2:00:00

2:35:43

Opening remarks and agenda

Presentation

0:28 → 2:30(2m 2s)

Chair opened the hearing, framed the topic as kratom and 7‑hydroxymitragynine (7OH) with an emphasis on public‑health risks and regulatory gaps in California, noted prior bills and that AB 1088 will be considered later this year, outlined hearing format and public comment rules.

Keywords:

Speakers:

Informational hearing by the California State Senate Health Committee on kratom and 7‑hydroxymitragynine (7OH), featuring public‑health officials, clinicians, medical examiners, industry representatives, advocates, and lengthy public comment about risks, testing limitations, and possible regulatory responses (AB 1088 discussed).

AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Transcript

Unlock the transcript with a paid subscription